Recall StatusOpen, Classified
Date Initiated2021-07-06
Product Quantity580 units
Reason for Recall
Product does not meet the Instructions for Use (IFU) claimed Pack Calibration Interval of 10 days. IFU calibration updated interval from 10 days to 3 days for all current and future kit lot numbers
Firm Action
Siemens Healthcare issued Urgent Medical Device Correction (UMDC) via FedEx beginning on 07/06/2021. An Urgent Field Safety Notice (UFSN) was issued to all OUS Siemens sites with affected customers electronically for distribution and regional reporting to their local competent authorities beginning on 07/06/2021.
Letter states reason for recall, health risk and action to take:
Please review this letter with your Medical Director.
Change the BR assay Pack Calibration Interval on each Atellica IM analyzer from 10 days
to 3 days. See Additional Information for instructions on changing the Pack Calibration
Interval.
All Atellica IM BR assay kit lots can continue to be utilized with the updated Pack
Calibration Interval of 3 days.
Continue to follow the Atellica IM BR IFU claimed 28-day On-board Stability and 32-day Lot Calibration Intervals.
Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days.
If you have received any complaints of illness or adverse events associated with the
products listed in Table 1, immediately contact your local Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative.
Please retain this letter with your laboratory records and forward this letter to those who may have received this product.
If you have any questions, please contact your Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative.
Additional Information
Instructions for Changing the Pack Calibration Interval on Atellica IM Analyzers
Instructions for updating the BR Pack Calibration Interval from 10 days to 3 days on each Atellica
IM analyzer are outlined below.
1) Sign into Atellica IM analyzer as Labmanager user level
2) In the Worklist Overview screen, move all BR results to Historical
3) In the Setup screen, select Test Definition, select IM Test Definition, and select BR Test
4) Select the Calibration Tab
5) Under Pack C
Root Cause
Under Investigation by firm
Distribution Pattern
Worldwide distribution. US Nationwide, Australia, Bahamas, India, Mexico, Saudi Arabia, and Viet Nam
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.